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Abstract  66 
 67 
Background 68 
Measurement of multiple food intake exposure biomarkers in urine may offer an 69 
objective method for monitoring diet. The potential of spot and cumulative urine 70 
samples that have reduced burden on participants as replacements for 24-hour urine 71 
collections has not been evaluated. 72 
 73 
Objectives 74 
The aim of this study was to determine the utility of spot and cumulative urine samples 75 
for classifying the metabolic profiles of people according to dietary intake when 76 
compared with 24-hour urine collections in a controlled dietary intervention study. 77 
 78 
Design 79 
19 healthy individuals (10 male, 9 female, aged 21 – 65, BMI 20 – 35 kg/m2), each 80 
consumed four distinctly different diets, each for 1 week. Spot urine samples were 81 
collected approximately 2 h post meals on three intervention days each week. 82 
Cumulative urine samples were collected daily over three separate temporal periods. 83 
A 24-hour urine collection was created by combining the three cumulative urine 84 
samples. Urine samples were analysed using metabolite fingerprinting by both high-85 
resolution flow infusion mass spectrometry (FIE-HRMS) and proton nuclear magnetic 86 
resonance spectroscopy (1H-NMR). Concentrations of dietary intake biomarkers were 87 
measured using liquid chromatography triple quadrupole mass spectrometry (LC-88 





Cross-validation modelling using 1H-NMR and FIE-HRMS data demonstrated the 92 
power of spot and cumulative urine samples in predicting dietary patterns in 24-hour 93 
urine collections. Particularly there was no significant loss of information when post –94 
dinner (PD) spot or overnight cumulative samples were substituted for 24-hour urine 95 
collections (classification accuracies 0.891 and 0.938 respectively). Quantitative 96 
analysis of urine samples also demonstrated the relationship between post-dinner 97 
(PD) spot samples and 24-hour urines for dietary exposure biomarkers. 98 
 99 
Conclusions 100 
We conclude that PD spot urine samples are suitable replacements for 24-hour urine 101 
collections. Alternatively, cumulative samples collected overnight predict similarly to 102 
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The frequency and pattern of consumption of foods and beverages are major 111 
determinants of the risk of obesity and of multiple health outcomes (1,2). As a 112 
consequence, the World Health Organisation and many governments have introduced 113 
population-based policies, which aim to improve eating patterns and to reduce the 114 
burden of chronic diseases (3). However, evaluation of the impact of public health 115 
policies on dietary intake in populations is challenging. Traditionally, the assessment 116 
of dietary exposure has been wholly reliant on a range of self-reported measures such 117 
as Food Frequency Questionnaires (FFQs), recall and diet diaries. These methods 118 
are often inaccurate due to significant misreporting and bias by individuals (4). The 119 
data quality of these approaches can be improved upon if the collection is supervised 120 
by a trained researcher, however the cost of this will often be prohibitive for meaningful 121 
sample sizes in large scale epidemiological studies. Additionally, conventional tools 122 
based on dietary self-reporting can be tedious and time-consuming for both study 123 
participants and investigators. Whilst the advent of digital (including on-line) tools may 124 
assist with the challenge of daily dietary recording and reduce the workload for both 125 
respondents and researchers (5), this does not eliminate the subjectivity and biases, 126 
which is inherent for approaches based on self-reporting (6–8). With obesity and 127 
chronic disease levels continuing generally to rise each year there is an urgent need 128 
both for accurate and scalable technologies to assess diet at the level of both 129 
population and the individual. 130 
Many foods contain characteristic, non-nutritive, secondary metabolites which after 131 
consumption undergo metabolism often at multiple sites prior to elimination from the 132 
body (9). Metabolomic analyses have been previously applied to biofluids in human 133 
studies, particularly to blood, saliva and urine, to discover novel metabolite biomarkers 134 
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of food intake (10–12) and more recently to detect patterns of overall dietary status 135 
(13–15). Urine can be considered the biological fluid of choice because of the ease of 136 
collection and, unlike blood, it provides an integrated estimate of exposure over 137 
several hours. 138 
In studies evaluating the potential of urinary biomarkers to report dietary exposure, 139 
biomarker performance is often only examined in highly controlled dietary 140 
interventions, typically based on exposure to a single meal (16,17). In very few 141 
instances have such biomarker leads been validated and tested for specificity using 142 
dietary records and urine sample sets collected under epidemiological study 143 
conditions (18,19). 144 
To have significant utility in the future it is essential that any emerging technology 145 
allows for the simultaneous measurement of multiple biomarkers, which can then be 146 
used to provide comprehensive coverage of dietary exposure in a real-world 147 
environment. A key requirement to achieve this objective is the development of a 148 
suitable approach for the sampling of urine to capture an accurate representation of 149 
eating behaviour, but which has minimal impact on an individual’s daily activities. The 150 
assessment of dietary exposure using only urinary analysis is a challenging prospect. 151 
The frequency that foods are consumed varies between individuals and many foods 152 
are consumed typically within complex meals and as a variety of formulations and after 153 
different processing methods. Additionally, the presence and concentration of food 154 
biomarkers in any urine void will be modulated by the timing of dietary intake. In many 155 
research studies requiring accurate quantification of the daily excretion of a specific 156 
analyte the adopted ‘gold standard’ method for sampling demands the collection of all 157 
urine voids over a full day (24-hour urine) (20,21). 158 
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While a 24-hour urine can provide robust and accurate quantification of analytes its 159 
collection imposes a significant burden on study participants due to its adverse impact 160 
on normal daily activities (22). There is also a significant risk that measurements are 161 
misreported due to incorrect collections; in some studies it has been shown that up to 162 
30 % of 24-hour collections are under-collections (23). In contrast to 24-hour urine, 163 
collection of spot urine samples has a reduced impact on normal daily activities and 164 
benefit from cheaper logistical costs. Against this background, if 24-hour collections 165 
could be substituted by spot samples or less burdensome cumulative/pooled urine 166 
samples representing specific temporal phases of the day, then the scale up of cohort 167 
size in nutritional epidemiological studies would be feasible and improve the accuracy 168 
of dietary assessment using urinary biomarkers at the population level. The main 169 
objective of the present study is to determine whether spot urines, or pooled urine 170 
samples (cumulative samples) representing specific temporal phases of the day, can 171 
adequately substitute for 24-hour urine samples in dietary exposure studies. 172 
Materials and Methods 173 
 174 
Study Design 175 
 176 
Urine samples were obtained from 19 healthy individuals (10 male, 9 female, 21 – 65 177 
years; BMI 20 – 35 kg/m2) who participated in a randomised, controlled, crossover 178 
short-term food intervention (13) in which they were exposed to four diets with a 179 
stepwise degree of concordance with World Health Organisation’s (WHO) dietary 180 
guidelines (24). Each diet differs in the contribution of macro and micro nutrients to 181 
total daily energy intake. Diet 1 (100%) was the most concordant, Diet 4 (25%) the 182 
least concordant, and Diets 2 (50%) and 3 (75%) were the intermediate diets. 183 
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Participants attended the Clinical Research Facility (CRF) for a 72-hour inpatient 184 
period on four separate occasions. Each inpatient stay was separated by a minimum 185 
of 5 days to ensure that any potential carryover from the dietary intervention periods 186 
was minimised. Adherence to the study protocol was strictly monitored during the 187 
inpatient stay. All food was weighed immediately before being given to the participants 188 
and any uneaten food was weighed. Physical activity was controlled; and participants 189 
were only allowed to engage in very light physical activity.  190 
At each visit, the same menu plan was consumed every day for each of the 3 days 191 
within a single experimental period to ensure that a stable dietary exposure was 192 
established. The manipulated foods for each diet are detailed in Supplemental Table 193 
1 of the following reference (13). During each 3 day dietary intervention, urine samples 194 
were constantly collected as previously described (13). Spot urines were collected in 195 
a fasted state (FA) each morning and approximately 2h after the consumption of each 196 
meal (post-breakfast, PB; post-lunch, PL and post-dinner, PD). Cumulative urine 197 
samples were collected to represent 3 temporal phases of each day. Cumulative 198 
sample 1 (CS1) was all urine from the 4h period post-breakfast to pre-lunch. 199 
Cumulative sample 2 (CS2) was all urine from the 5h period post-lunch to pre-dinner. 200 
Cumulative sample 3 (CS3) was all urine from the 13h period post-dinner to the fasting 201 
urine the following morning. A 24-hour (24HR) urine sample was prepared by pooling 202 









Urine samples were thawed to room temperature, vortexed and 800 µL transferred to 210 
a clean 2 mL Eppendorf tube. Samples were centrifuged (EBA 12 R, Hettich) at 25,200 211 
g for 5 minutes at 4 ºC. Following centrifugation, specific gravity of a 200 µL aliquot 212 
was measured using a hand-held refractometer (OpitDuo 38-53, Bellingham and 213 
Stanley). Specific gravity correction factors were calculated per participant as the fold 214 
change of individual sample specific gravity to the specific gravity of the sample in the 215 
whole sample set which recorded the minimum value (25). Extracts were then 216 
prepared as previously described (26).  217 
 218 
Flow infusion metabolite fingerprinting and data pre – processing 219 
 220 
All samples were analysed using high-resolution flow infusion mass spectrometry 221 
(FIE-HRMS). From each extracted sample, 20 µL was transferred to a glass HPLC vial 222 
containing a 200 µL flat bottom micro insert (Chromacol) and diluted with 80 µL of 223 
H2O:MeOH (3:7) directly in the vial. Mass spectra were acquired on an Exactive 224 
Orbitrap (ThermoFinnigan, San Jose CA) mass spectrometer coupled to an Accela 225 
(ThermoFinnigan, San Jose CA) ultra-performance liquid chromatography system. 20 226 
μL of sample was injected and delivered to the ESI source via a flow solvent (mobile 227 
phase) or pre-mixed HPLC grade MeOH (Fisher Scientific) and ultra- pure H2O (18.2 228 
Ω) at a ratio of 7:3. The flow rate was 200 μLmin-1 for the first 1.5 minutes, and 600 229 
μLmin-1 for the remainder of the method. The total assay time was 3.0 minutes. 230 
 231 
Positive and negative ionisation modes were acquired simultaneously. One scan event 232 
was used to acquire all mass spectra, 55.000 - 1000.000 m/z and 63.000 - 1000.000 233 
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m/z for positive and negative mode respectively. The scan rate was 1.0 Hz. Mass 234 
resolution was 100,000, with an automatic gain control (AGC) of 5 x 105 and maximum 235 
ion injection time of 250 ms, for both ionisation modes. Following data acquisition raw 236 
profile data (RAW, ThermoFinnigan) were converted to the mzML open file format and 237 
centroided (27). Conversion and centroiding was performed using msconvert 238 
(TransProteomicPipeline) (28). All further processing of mzML files was performed 239 
using the R Statistical Programming Language (29). Dimensionality reduction of the 240 
acquired mass spectra was performed by taking each m/z value from scans about the 241 
apex of the infusion profile and binning the m/z and intensity values at 0.01 amu 242 
intervals. The result was a m x n matrix, where m is the sample and n is the m/z feature 243 
and cells are the respective average intensity values. The result matrix was filtered to 244 
yield only variables which were present at an occupancy greater than or equal to 70 % 245 
in at least of one the specified biological classes. This resulted in 4574 and 4362 246 
features for spot and cumulative (including 24 hour) urine samples respectively. 247 
 248 
 249 
Quantification of dietary exposure biomarkers by targeted Liquid 250 
Chromatography- Mass Spectrometry.  251 
 252 
Concentrations of selected biomarkers (see Table 1) were measured in selected urine 253 
samples using ultra-high-performance liquid chromatography (UHPLC) triple 254 
quadrupole (QQQ) mass spectrometry (MS) operating in Multiple Reaction Monitoring 255 
(MRM) mode. The dietary exposure biomarkers selected for quantification reflected 256 
the food components used in the diet interventions and included metabolites that were 257 
expected to eliminated from the body relatively quickly, as well as metabolites derived 258 
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as a result of gut microbiome activity  that were expected to appear in urine at later 259 
time points. MRM chromatograms were acquired on a TSQ Quantum Ultra QQQ mass 260 
spectrometer (ThermoFinnigan, San Jose CA) equipped with a heated electrospray 261 
ionisation (HESI) source and coupled to an Accela UHPLC system. The UHPLC 262 
system was equipped with either a reverse phase (C18) column or a polymeric 263 
Hydrophilic Interaction (pHILIC) column. Full chromatographic details are provided in 264 
Supplemental Section 1. Mass spectra were acquired using MRM acquisition, in 265 
positive and negative ionisation mode simultaneously. Collision energy and tube lens 266 
voltage values were optimised individually for each parent – product transition 267 
(Supplemental Table 1). All post-acquisition data processing was performed using 268 
Quan Browser (ThermoScientific) and Xcalibur (Thermo Scientific). Spearman rank 269 
correlations (Table 4 and 5) were performed using the R function; cor. Adjusted 270 
coefficient of determination (R2) values (Table 4 and 5) were calculated in R using the 271 
lm function.  272 
 273 
Statistical analysis of flow infusion metabolite fingerprinting data  274 
All statistical and classification analysis of flow infusion metabolite fingerprinting data 275 
was performed using the R Statistical Programming Language (29). Classification of 276 
metabolite fingerprint data was performed using the randomForest R package (Version 277 
4.6) (30). For all classification models, the dietary intervention (i.e. 25, 50, 75 and 278 
100% of WHO healthy eating guidelines) was the response variable. Models were 279 
constructed using all m/z variables 4574 and 4362, for spot and cumulative samples 280 
respectively. For each Random Forest model, the number of trees was 1000 and the 281 
number of variables considered at each internal tree node was the square root of the 282 
total number of available variables. Each model was assessed using classification 283 
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accuracy and multi-class area under the receiver operator characteristic (ROC) curve 284 
(AUC) (31). ROC-AUC values were calculated using the R package HandTill2001 285 
(Version 0.2-12).  For Figure 2 the training proximity values and predicted proximity 286 
values were used to construct a dissimilarity matrix (1 – proximity) which was then 287 
scaled to two dimensions using multidimensional scaling (MDS).  288 
 289 
1H-NMR acquisition and processing for metabolic fingerprinting and 290 
quantitative data 291 
Samples for 1H-NMR spectroscopy analysis were prepared mixing 540 μL of urine with 292 
60 μL of a pH 7.4 phosphate buffer as described previously (13). We analysed the 293 
samples at 300 K on a 600MHz spectrometer (Bruker BioSpin, Karlsruhe, Germany) 294 
using a standard one-dimensional pulse sequence with water-pre-saturation (32). As 295 
described previously (13), 1H-NMR spectra were modelled with Partial Least Squares 296 
Discriminant Analysis (PLS-DA) in a repeated-measures Monte Carlo Cross-Validation 297 
(MCCV) framework. The mean prediction (Tpred) was estimated across the MCCV 298 
models where the sample was left-out of modelling. A positive Tpred indicated that the 299 
urinary metabolic profile of the sample resembled Diet 1 more than Diet 4, and vice 300 
versa for a negative Tpred. Variable importance was assessed based on bootstrap 301 
resampling of regression coefficients in each model, using the False Discovery Rate 302 
(q-value) of ≤0.01 to indicate significance. Skillings-Mack tests were used to assess 303 
differences between the four diets (multiple paired samples) (13). Subsequently, 304 
Wilcoxon’s signed rank test was used to test pairwise differences and p values from 305 







Dietary exposure is well discriminated by metabolite fingerprinting using spot, 311 
cumulative or 24-hour urine samples 312 
 313 
Multidimensional scaling (MDS) of multinomial Random Forest classification models 314 
for diet differences in metabolome fingerprint data demonstrated excellent separation 315 
between diets with all three urine types from Day 3 (Figure 1). It is evident that urine 316 
composition reflective of the 4 different diets had already stabilised by Day 2 317 
(Supplemental Figure 1). These findings were validated by the 1H-NMR metabolic 318 
fingerprinting models (13) that showed good discrimination between dietary 319 
intervention on Day 1 (Skillings-Mack P=8.20 x 10-7), Day 2 (Skillings-Mack P=7.11 x 320 
10-10) and Day 3 (Skillings-Mack P=7.21 x 10-9) based on 24-hour samples, with the 321 
lowest significance values achieved using Day 1 urine samples. Classification 322 
performance of CS3 models was comparable with those obtained for PD spot 323 
models and 24-hour urine samples for both Day 3 (Figure 1) and Day 2 324 
(Supplemental Figure 1) samples. Comparable results were obtained using 1H-325 
NMR metabolic fingerprinting modelling which demonstrated that PD spot urine and 326 
CS2 and CS3 models all significantly discriminated between dietary treatments, with 327 
the PD spot model having the lowest classification values (13). 328 
 329 





Principal Component Analysis (PCA) was performed on an exemplar FIE-HRMS 333 
dataset to confirm that sample type was not a confounding factor (Supplemental 334 
Figure 2). The PCA model was constructed using spot samples only and the 335 
corresponding cumulative sample data were projected into the PCA model. This 336 
showed that sample type did not result in an observable change in model structure. 337 
Experimental cross validation was used to determine if discrimination between all diets 338 
measured in a spot urine sample type predicted diet correctly in unlabelled urines of a 339 
different type (i.e. cumulative or 24-hour).   As an example, a Random Forest model 340 
was trained to discriminate between the 4 different diets using Day 3 PD spot urine 341 
fingerprint data and then diet was predicted in Day 3 24-hour urine samples. 342 
Multidimensional scaling (MDS) of predicted Random Forest proximity values 343 
demonstrated good correspondence of PD and 24-hour urine collection data following 344 
exposure to each of the 4 different diets. Classification performances for all urine type 345 
comparisons (using both FIE-HRMS and NMR data) based on Day 3 urine samples 346 
are shown in Supplemental Table 1 and Supplemental Table 2. In Table 2 the 347 
results are shown where Day 3 PD spot samples only have been used to construct 348 
training models and predictions made concerning all samples types on both Day 2 and 349 
Day 3. Likewise, cumulative samples were used to predict diet discrimination in 24-350 
hour urine samples, cumulative and spot samples (Table 3). The full dataset 351 
(Supplemental Table 1), in which PB and PL spot samples were used to construct a 352 
training model, demonstrates the power of spot urine samples to predict dietary 353 
patterns. In summary, 15 out of 30 FIE-HRMS models (Supplemental Table 1) yielded 354 
a classification accuracy of > 0.9 and only10 models had performance of < 0.9 > 0.8 355 
A key highlight from the classification modelling was confirmation of the ability of spot 356 
samples to predict accurately their corresponding temporal phase cumulative sample. 357 
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For example, PB-3 (training) and CS1-3 (test) gave an accuracy of 0.974, PL-3 358 
(training) and CS2-3 (test) gave an accuracy of 0.975. In addition, PD-3 (training) and 359 
CS3-3 (test) yielded an accuracy of 0.918. Furthermore, the PD-3 spot sample 360 
predicted dietary exposure in the corresponding Day 3 24-hour (24S-3) sample, with 361 
an accuracy of 0.891. All of the FIE-HRMS models were validated by the 1H-NMR 362 
analysis using the same sample model combinations. In all instances where 363 
classification accuracy was > 0.9, Skillings-Mack significance testing (p-value) 364 
indicated strong coherence between the two independent, non-targeted analytical 365 
platforms (Tables 2 and 3). As expected, with both analytical platforms and modelling 366 
approaches, the best predictions were achieved when the sample collection of the 367 
training model was time-matched as closely as possible with the test samples. 368 
 369 
 370 
Dietary biomarkers exhibit similar quantitative changes in both PD spot urines 371 
and 24-hour urine collections on exposure to different amounts of specific foods 372 
 373 
Table 4 shows the correlations between the concentration of key dietary biomarkers 374 
in PD spot and 24-hour urine samples respectively. The biomarkers selected (see 375 
Table 1) included metabolites that were the product of biotransformation within the 376 
human body (e.g. 3,5-Dihydrophenylpropionoic acid 3-O-sulfate and D-L-377 
Sulforaphane-N-acetyl-L-cysteine) and others which were eliminated from the body 378 
without biotransformation within a few hours after consumption (e.g. L-Anserine and 379 
tartrate). Spearman rank correlation coefficients (ρ) ranged from 0.447 to 0.959. The 380 
accuracy of each comparison was measured using the adjusted R 2 value from linear 381 
models between quantitative measures in PD and 24-hour urine samples (Table 4). 382 
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Adjusted R2 values showed the same distribution in variability as the spearman rank 383 
correlation coefficients across the biomarkers. Dihydrophenylpropanoic acid (DHPPA) 384 
exhibited a weak correlation between PD and 24-hour urine samples (ρ = 0.147, R2 = 385 
0.451) and PD versus CS3 (ρ = 0.147, R2 = 0.451). In this case, the relatively weak 386 
correlations between urine sample types is due to the fact that DHPPA, a biomarker 387 
of wholegrain consumption is eliminated from the body relatively slowly over several 388 
hours after wholegrain consumption (33,34). Therefore, because the wholegrain 389 
containing foods were consumed at breakfast and/or lunch DHPPA excretion is not 390 
captured adequately in the PD spot but is present in the 24-hour and CS3 samples. 391 
The range of correlation coefficients is reflective the unique absorption, metabolism 392 
and excretion dynamics of each of the biomarkers. While there were variations in 393 
correlation coefficients, the relative distribution of analytes between sample type 394 
remained consistent (see Supplemental Figure 3 for Quantile-Quantile Plots). In all 395 
cases a right skew is visible indicative of the complex dynamic range of dietary 396 
biomarkers within urine. 397 
 398 
 399 
Micturition characteristics supports sample homogeneity between different 400 
urine sample types 401 
Inter-individual variation in water intake and micturition behaviour compounds the 402 
challenge of obtaining objective dietary information using urinary biomarkers. To have 403 
value for estimation of dietary intake it is essential that spot urine samples can be 404 
normalised to account for differences in inter-individual variation in micturition 405 
behaviour. In all three sample types the relationship between refractive index and 406 
creatinine concentration was consistent (Supplemental Figure 4). Wilcox-signed rank 407 
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test between PD urine creatinine concentrations and 24-hour urine creatinine 408 
concentrations showed no change in rank positions (P = 0.586). Similar results were 409 
also observed for the comparison of refractive index between sample types. A weak 410 
significant difference (0.01<P<0.05) was observed between refractive index values in 411 
CS3 and 24-hour urine samples. With no deviation between creatinine concentrations 412 
and refractive index across sample types there is no loss of accuracy in using pre-413 
analytical physical measurements (refractive index) to determine sample 414 
concentration and normalise prior to analysis. 415 
 416 
Discussion  417 
The study design allowed us to compare the utility of spot, cumulative phase and 24-418 
hour urine samples for quantifying biomarkers of dietary exposure. Because 419 
individuals consumed the same diet for three consecutive days in each experimental 420 
period, metabolic responses to each experimental diet stabilized within about 24-hours 421 
and the study design provided an opportunity for substantial replication, cross-422 
validation and assessment of variability (13). In addition, we undertook non-targeted 423 
metabolite fingerprinting by two different analytical methods (FIE-HRMS and NMR) to 424 
provide a comprehensive representation of urine chemistry. 425 
 426 
24-hour urine collection, for example for determination of sodium intake, is recognized 427 
as being expensive and burdensome (35). If urine is to be used for large-scale 428 
biomarker-based investigations of dietary exposure, then simpler, less burdensome 429 
methods of urine collection are needed. The collection of a single spot urine sample 430 
imposes much less burden on individuals compared with 24-hour urine collection and 431 
has a reduced impact on an individual’s daily activities. An essential criterion of any 432 
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urine sampling method is that it provides an accurate estimation of habitual eating 433 
behavior. Because hydration levels and micturition frequencies differ between 434 
individuals the utility of spot urines for dietary exposure assessment is dependent on 435 
simple methods to normalize concentration differences (36). Creatinine has been used 436 
widely as a measure for determining total urine concentration (37). Measurement of a 437 
physical attribute reflecting overall urine concentration, such as refractive index or 438 
osmotic concentration also provides a simple method to correct for differences in 439 
individual hydration status (25,38). An advantage of using a physical characteristic as 440 
a surrogate for sample concentration is that it accounts for the entire non-water content 441 
of the urine and is not dependant on the utility of any single analyte such as, creatinine, 442 
which itself can be confounded by intake of red meat or renal disease. In addition, pre-443 
analytical normalisation has the advantage that it is independent of the analytical 444 
process for metabolite quantification (25). 445 
 446 
From the present study, spot urine samples collected at least two hours post 447 
consumption of the main evening meal were found to be the best substitute for 24-448 
hour urine collections. Although more burdensome to collect (compared to a spot 449 
urine), CS3 samples (collected from the 13-hour period after eating an evening meal 450 
to the fasting urine) followed by the CS2 samples (collected from the 5-hour period 451 
post-lunch to pre-dinner) were the best substitutes for 24-hour urine samples. Although 452 
dietary exposure biomarkers will be present at different concentrations in spot urine 453 
samples collected at different times after consumption of specific foods, the present 454 
study illustrates that exposure levels to several key foods of high public health interest 455 
can be assessed equally well in 24-hour, cumulative and spot urine samples. However, 456 
in order to minimize the limitations of spot sample variability, they must be collected in 457 
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an informative, relatively narrow time window. In situations where it is very difficult to 458 
obtain a spot sample in a narrow time window, cumulative samples have been 459 
demonstrated to predict similarly to 24-hour urine samples and have the advantage of 460 
being a lower collection burden for participants (13). 461 
 462 
There have been relatively few studies describing targeted quantitative analyses of 463 
multiple biomarker chemical classes in urine samples. In the present study all 464 
participants were obliged to eat identical meals at the same time under supervision to 465 
ensure optimal compliance and enabling accurate alignment of biomarker excretion 466 
profiles in the different urine types. A recent review by Dragsted et al (39), stressed 467 
the importance of ‘time response’ as a characteristic to consider when choosing 468 
sample types for biomarker quantification.  Although correspondence of biomarker 469 
levels between PD spot and 24-hour urine collections was generally good 470 
(Supplemental Figure 5), the presented data illustrates that weaker correlations 471 
between dietary intake and biomarker concentrations in both spot and 24-hour urine 472 
samples may also be expected; particularly in epidemiological studies where the time 473 
elapsed between eating and urine sampling is not tightly controlled biomarkers derived 474 
from colonic fermentation may not be highly represented in PD urine samples and so 475 
the use of First Morning Void (FMV) urine sampling in addition might be recommended. 476 
A typical example would be skewed distribution towards lower concentrations 477 
measured in PD spot urine for D-L-Suforaphane (a biomarker of exposure to 478 
cruciferous vegetables) (40,41) at higher dietary intake levels, which is derived from 479 
colonic fermentation and additionally may reflect the impact of metabotype differences 480 
within a specific population. For these hypotheses to be further investigated these 481 
methods first need scaling to the population level and testing in a representative 482 
21 
 
epidemiological contexts. Taking note of any possible complications arising, with 483 
regard to the behavior of specific biomarkers we suggest that in future PD spot or the 484 
CS3 urine voids in combination with FMV urines may provide ideal samples for 485 
epidemiological studies requiring assessment of dietary exposure. Their ease of 486 
collection by the participant and storage offer scope for assessing food intake on 487 
multiple days with little impact on the normal daily activities of individuals. We propose 488 
that dietary exposure biomarker technology in conjunction with traditional self-489 
reporting tools should help improve the quality of future nutrition research. 490 
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Table 1:   Analytical details of biomarkers used for absolute quantification in urine 













1 – Methylhistidine Poultry / 
Fish 
170.064 (+) 124.160 9.57 3.17 (2d), 3.22 (2d), 3.78 
(s), 3.99 (dd), 7·17(s), 
8·12 (s) 
3 – Methylhistidine Total meat 170.059 (+) 95.345 10.4 3.25 (2d), 3.30 (2d), 3.78 
(s), 3.99 (dd), 7·23(s), 
8·27 (s) 
L-Anserine Poultry / 
Fish 
241.052 (+) 109.159 10.95  
Carnosine Total meat 227.064 (+) 110.202 11.66  
Trimethylamine-N-
oxide 




Wholegrain 181.044 (-) 137.132 4.22 *  
3,5-
Dihydrophenylpropio
noic acid 3-O-sulfate 
Wholegrain 260.950 (-) 95.225 3.89 *  
D-L-Sulforaphane Cruciferous 
vegetables 





299.003 (+) 114.103 3.92 *  
Tartaric acid Grapes 149.016 (-) 87.191 13.15 4.34(s) 
7-Methylxanthine Cocoa 167.085 (+) 150.130 3.53 *  
3-Methylxanthine Cocoa 167.096 (+) 94.22 3.67 *  
3-Methyluric acid Cocoa 181.009 (-) 138.078 9.55  
Caffeine Coffee / 
Caffeinated 
drinks 










477.076 (-) 300.972 5.2 *  
Rhamnitol Apple    1.28 (d) 
O-acetylcarnitine Red Meat    2.15 (s), 3.19 (s) 
Carnitine Red Meat    2.44 (dd), 3.23 (s), 3.43 
(m) 





   2.78 (s) 
Glucose 
 
Sugars    3.42 (m), 3.49 (m), 3.54 







Onion    1.96 (dd), 2.03 (s), 6.49 
(dq), 6.65 (dq) 
N-methylnicotinate Peas & 
Niacin 
   4.44 (s), 8.10 (t), 8.84 
(d), 9.11 (s) 




1: All parent ions were detected as either the protonated (M+H) or deprotonated (M-
H) form of the mono-isotopic mass (M) of each biomarker. Parent ions denoted with 
(+) or (-) indicates that the biomarker was detected in the protonated or deprotonated 
form respectively. 2: For each parent ion a minimum of three product ions were 
detected and analysed. The product ions shown are the ones which demonstrated the 
greatest stability and were therefore used for quantification. The remaining product 
ions (not shown) were used as qualifying ions only. 3: Retention times denoted with an 
* indicate that ultra-high-performance chromatography of the specified biomarker was 
performed on a RP-C18 column. All other biomarkers were analysed using a ZIC-
pHILIC column.  4: The chemical shifts and multiplicities are listed for peaks from 
significantly associated metabolites. Multiplicity key is as follows: s – singlet, d – 
doublet, t – triplet, q – quartet, dd –doublet of doublets, dq – doublet of quartets, 2d – 

























Table 2:   Predicted classification scores from Post-dinner (PD) day 3 spot samples and 



























1 Sample type used for model training. 2 Sample type used for model prediction.  3 Skillings-
Mack p-value are from Monte-Carlo cross validation (MCCV) of 1H NMR data.  4 
Classification accuracy is the resampled (n = 100) prediction accuracy of multinomial 













 (95 % CI) 4 
 
PD-3 PB-2 1.16×10-02 
0.613 
(0.600,0.625) 
PD-3 PB-3 8.89×10-04 
0.678 
(0.664,0.691) 
PD-3 PL-2 3.48×10-06 
0.814 
(0.803,0.824) 
PD-3 PL-3 2.30×10-10 
0.795 
(0.784,0.806) 
PD-3 PD-2 3.53×10-06 
0.976 
(0.971,0.98) 
PD-3 PD-3 1.99×10-11 
1.000 
(1.000,1.000) 
PD-3 CS1-3 9.43×10-08 
0.684 
(0.671,0.697) 
PD-3 CS2-3 1.29×10-11 
0.969 
(0.964,0.973) 
PD-3 CS3-3 2.06×10-10 
0.918 
(0.911,0.926) 





Table 3:   Predicted classification scores from Cumulative day 3 (CS3) samples and spot 












(95 % CI) 4 
 
CS3-3 PB-2 1.05×10-04 
0.701 
(0.688,0.714) 
CS3-3 PB-3 2.92×10-03 
0.736 
(0.725,0.747) 
CS3-3 PL-2 2.94×10-06 
0.747 
(0.735,0.759) 
CS3-3 PL-3 8.34×10-08 
0.748 
(0.735,0.760) 
CS3-3 PD-2 4.31×10-06 
0.988 
(0.986,0.991) 
CS3-3 PD-3 2.12×10-11 
1.000 
(1.000,1.000) 
CS3-3 CS1-3 3.30×10-06 
0.754 
(0.743,0.766) 
CS3-3 CS2-3 7.32×10-11 
0.821 
(0.810,0.833) 
CS3-3 CS3-3 9.69×10-10 
1.000 
(1.000,1.000) 




1 Sample type used for model training. 2 Sample type used for model prediction.  3 Skillings-
Mack p-value are from Monte-Carlo cross validation (MCCV) of 1H NMR data.  4 
Classification accuracy is the resampled (n = 100) prediction accuracy of multinomial 




Table 4:  Comparison of absolute quantitation values between Post-dinner (PD) spots and 
24-hour urine samples 
 
Biomarker R2 1 Spearman Rank (ρ) 2 
Creatinine 0.314 0.602 
1-Methylhistidine 0.306 0.611 
Anserine 0.879 0.931 
Carnosine 0.440 0.690 
Trimethylamine-N-Oxide 0.733 0.920 
3-Methylhistidine 0.834 0.891 
3-Methyluric-acid 0.528 0.846 
Tartrate 0.500 0.871 
3-Methyl-xanthine 0.797 0.941 
7-Methyl-xanthine 0.891 0.959 
Caffeine 0.399 0.837 
DHPPA 0.147 0.451 
DHPPA-3-sulfate 0.553 0.838 
Ferulate-4-O-sulfate 0.369 0.731 
Quercetin-3-O-D-glucuronide 0.198 0.474 
D-L-Sulforaphane 0.788 0.820 
D-L-Sulforaphane-N-acetyl-L-cysteine 0.735 0.858 
Rhamnitol 0.251 0.539 
O-acetylcarnitine 0.007 0.505 
Carnitine 0.225 0.645 
Dimethylamine 0.343 0.470 
N-acetyl-S-methyl-cysteinesulfoxide 0.247 0.604 
Glucose 0.182 0.456 
N-acetyl-S-(1Z)-propenyl-cysteinesulfoxide 0.280 0.578 
N-methylnicotinate 0.271 0.664 
4-hydroxyhippurate 0.124 0.447 
 
 1 R2 is the adjusted coefficient of determination for linear models between biomarker 
quantifications in PD spot and 24-Hour urines samples. 2 ρ values are the correlation 




Table 5:  Comparison of absolute quantitation values between Post-dinner (PD) spots and 
Cumulative sample (CS3) 
 
Biomarker R2 1 Spearman Rank (ρ) 2 
Creatinine 0.284 0.526 
1-Methylhistidine 0.348 0.673 
Anserine 0.509 0.866 
Carnosine 0.231 0.613 
Trimethylamine-N-Oxide 0.806 0.935 
3-Methylhistidine 0.808 0.860 
3-Methyluric-acid 0.722 0.888 
Tartrate 0.502 0.898 
3-Methyl-xanthine 0.731 0.924 
7-Methyl-xanthine 0.859 0.970 
Caffeine 0.466 0.783 
DHPPA 0.182 0.499 
DHPPA-3-sulfate 0.609 0.838 
Ferulate-4-O-sulfate 0.362 0.626 
Quercetin-3-O-D-glucuronide 0.104 0.398 
D-L-Sulforaphane 0.700 0.774 
D-L-Sulforaphane-N-acetyl-L-cysteine 0.752 0.843 
Rhamnitol 0.198 0.538 
O-acetylcarnitine 0.361 0.608 
Carnitine 0.522 0.675 
Dimethylamine 0.381 0.589 
N-acetyl-S-methyl-cysteinesulfoxide 0.531 0.765 
Glucose 0.413 0.556 
N-acetyl-S-(1Z)-propenyl-cysteinesulfoxide 0.775 0.806 
N-methylnicotinate 0.373 0.710 
4-hydroxyhippurate 0.167 0.632 
 
1 R2 is the adjusted coefficient of determination for linear models between biomarker 
quantifications in PD spot samples and CS3 samples. 2 ρ values are the correlation 











Figure Titles and Legends 
 
Figure 1 Multidimensional scaling (MDS) of multinomial Random Forest 
classification models for diet differences in metabolome fingerprint data 
representing three different urine sample types.  
 
A; Post-dinner (PD) Day 3, B; Cumulative sample 3 (CS3)_Day 3 and C; 24-hour Day 3. 
Classification accuracies for A, B and C were 1.0, 0.93 and 0.89 respectively. Multi-class 
Area Under the ROC Curve (AUC) returned values of 1.0, 0.99 and 0.98 respectively.  
 
Figure 2 Multidimensional scaling (MDS) of predicted Random Forest proximity 
values in metabolite fingerprint data representing Post-dinner and 24-hour urine 
samples following exposure to the four different diets 
 
Blue symbols represent Post-dinner (PD) Day 3 samples which have been used to construct 
the training model. The red symbols are 24-hour urine Day 3 samples where diet (25, 50, 
75 and 100) has been predicted using the PD spot training model.  
 
 
